Monroe Carell Jr. Children's Hospital at Vanderbilt
Monroe Carell Jr. Children's Hospital at Vanderbilt
Monroe Carell Jr. Children's Hospital at Vanderbilt
Children's Hospital Logo
Connect With Us:

Monroe Carell Jr.
Children's Hospital
at Vanderbilt
2200 Children's Way
Nashville, TN 37232


(615) 936-1000

Children's Hospital Logo
Home / A–Z Services / Pediatric Surgery / Pediatric Orthopaedics / Research / Jonathan Schoenecker, M.D., Ph.D.
Printer friendly version of this page  E-mail someone a link to this pageBookmark and Share

Jonathan Schoenecker, M.D., Ph.D.

 

Jonathan Schoenecker, M.D., Ph.D., is a pediatric orthopaedic surgeon with a strong interest in defining the integrated role of coagulation and orthopaedics. His research has been refined by years of surgical training in musculoskeletal diseases in combination with basic science training in coagulation and bone biology. The focus of his research is the relationship between coagulation and bone biology; targeting how coagulation effects bone biology and how bone biology also effects coagulation.

Jonathan Schoenecker, M.D., Ph.D.

From the time that Dr. Schoenecker started to weave his basic science interests into his clinical studies, and vice versa, he realized that he wanted to have a translational component to his practice. He has made and attempts to keep his basic science interest one to two descriptive sentences away from his clinical practice.

Clinically, he enjoys treating an array of pediatric orthopedic conditions including, fractures, skeletal dysplasia and infections. Additionally, he also has a strong interest in developmental problems of the hip joint including Developmental Dislocation of the Hip, Perthes disease and Slipped Capital Femoral Epiphysis (SCFE). His ultimate goal is to be able to explain to his patients and families what exciting experiments he is doing in the lab in a manner they can relate to their disease.

Ultimately, he hopes that his research program will allow for the development of novel coagulation based pharmaceuticals capable of manipulating bone transplantation, fracture healing or inhibiting bone based tumors, as well as illuminate how pathologic conditions of coagulation in turn cause pathologic conditions of bone.

Dr. Schoenecker


Last Edited: December 20, 2012
Valued Participant of Vanderbilt Health Affiliated Network